HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MAPK11
mitogen-activated protein kinase 11
Chromosome 22 · 22q13.33
NCBI Gene: 5600Ensembl: ENSG00000185386.16HGNC: HGNC:6873UniProt: Q15759
140PubMed Papers
20Diseases
3Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneKinaseTranscription Factor
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
positive regulation of erythrocyte differentiationprotein serine/threonine kinase activityMAP kinase activityprotein bindingmetastatic colorectal cancercolorectal cancercolorectal neoplasmneoplasm
✦AI Summary

MAPK11 (p38β) is a serine/threonine kinase that functions as an essential component of the p38 MAPK stress-activated signaling cascade 1. As one of four p38 MAPK isoforms, MAPK11 plays important roles in cellular responses to extracellular stimuli including pro-inflammatory cytokines and physical stress, leading to activation of transcription factors 1. The kinase phosphorylates a broad range of substrates and exhibits largely redundant functions with MAPK14 (p38α) 1. MAPK11 promotes phosphorylation of key downstream targets including RBBP6 at Ser772, which leads to SIRT6 protein degradation in cancer-associated fibroblasts 1. In hepatocellular carcinoma, MAPK11 expression is transcriptionally activated by ETV4, contributing to TNF-α signaling and hepatic inflammation 2. The kinase also regulates extracellular matrix internalization and cancer cell migration through α2β1 integrin-mediated pathways 3. Additionally, MAPK11 promotes MAPK11-PML phosphorylation, which can be modulated by anesthetic agents like Ciprofol to reduce glioma recurrence 4. Expression analysis reveals that MAPK11 is generally downregulated in several female cancers including breast, endometrial, and ovarian cancers compared to normal tissue 5, while being upregulated in certain inflammatory conditions like idiopathic multicentric Castleman disease 6.

⚠Limited data available — This gene has 0 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ20
metastatic colorectal cancerOpen Targets
0.55Moderate
colorectal cancerOpen Targets
0.54Moderate
colorectal neoplasmOpen Targets
0.49Moderate
neoplasmOpen Targets
0.42Moderate
hepatocellular carcinomaOpen Targets
0.38Weak
gastrointestinal stromal tumorOpen Targets
0.35Weak
acute coronary syndromeOpen Targets
0.33Weak
Facioscapulohumeral dystrophyOpen Targets
0.29Weak
esophageal cancerOpen Targets
0.28Weak
malignant colon neoplasmOpen Targets
0.28Weak
COVID-19Open Targets
0.26Weak
neurodegenerative diseaseOpen Targets
0.26Weak
neuroinflammatory disorderOpen Targets
0.24Weak
colorectal adenocarcinomaOpen Targets
0.22Weak
cancerOpen Targets
0.14Weak
colorectal carcinomaOpen Targets
0.12Weak
chronic obstructive pulmonary diseaseOpen Targets
0.11Weak
major depressive disorderOpen Targets
0.11Weak
rectum cancerOpen Targets
0.11Weak
melanomaOpen Targets
0.10Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets3
LOSMAPIMODPhase III
MAP kinase p38 beta inhibitor
acute coronary syndrome
REGORAFENIBApproved
Discoidin domain-containing receptor 2 inhibitor
colorectal cancer
RWJ-67657Phase I
MAP kinase p38 beta inhibitor
arthritis
Related Genes
MAP2K1Protein interaction100%SP1Protein interaction99%MAPKAPK3Protein interaction99%FOXO3Protein interaction99%ESR1Protein interaction98%PTPN7Protein interaction96%
Tissue Expression6 tissues
Ovary
100%
Lung
92%
Heart
91%
Brain
53%
Liver
33%
Bone Marrow
28%
Gene Interaction Network
Click a node to explore
MAPK11MAP2K1SP1MAPKAPK3FOXO3ESR1PTPN7
PROTEIN STRUCTURE
Preparing viewer…
PDB3GP0 · 1.90 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
1.31LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF1.01 [0.79–1.31]
RankingsWhere MAPK11 stands among ~20K protein-coding genes
  • #3,281of 20,598
    Most Researched140 · top quartile
  • #911of 1,025
    FDA-Approved Drug Targets1
  • #13,750of 17,882
    Most Constrained (LOEUF)1.31
Genes detectedMAPK11
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
TSPAN8
PMID: 38569015
Sci Transl Med · 2024
1.00
2
Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-α signaling.
PMID: 37670477
Cancer Commun (Lond) · 2023
0.90
3
Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals.
PMID: 36775079
J Ethnopharmacol · 2023
0.80
4
p38β - MAPK11 and its role in female cancers.
PMID: 34174910
J Ovarian Res · 2021
0.70
5
P38 kinase in gastrointestinal cancers.
PMID: 37248432
Cancer Gene Ther · 2023
0.60